Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Articles|January 18, 2018
- Pharmaceutical Technology\'s In the Lab eNewsletter-02-07-2018
- Volume 13
- Issue 2
Automated Collector for Analytical Chromatography Applications
Author(s)Pharmaceutical Technology Editors
The NGC Fraction Collector from Bio-Rad Laboratories allows researchers to choose how to collect and when to access their fractions for analytical or preparative chromatography applications.
The NGC Fraction Collector from Bio-Rad Laboratories provides the flexibility and collection capacity needed for any analytical or preparative chromatography application when used with the company’s NGC Chromatography System.
Features include a benchtop Peltier cooling module for temperature-sensitive biomolecules and an optional enclosure to protect samples from environmental conditions while allowing full access during a run. Because the enclosure is optional, the same fraction collector can also be used for reverse-phase chromatography applications.
The unit, which runs on ChromLab 5.0 Software, allows researchers to choose how to collect and when to access their fractions. The system can be activated to collect based on slope, percent of buffer from pump B, pH, and detector signals. According to the company, front-to-back dispensing provides access to fractions before method completion for improved speed of downstream analysis. Researchers can also choose the type of collection vessel they prefer for each phase in a method, including deep-well plates, tubes, bottles, and carboys (with prep-rack adaptors for large-scale purification). Adding two new fraction collectors to each NGC System can further expand capacity, according to a company press release.
Source:
Articles in this issue
over 8 years ago
Metrohm USA Announces 6th Annual Young Chemist Award Winnerover 8 years ago
Corning and CytoSMART Partner on Cell Counting Deviceover 8 years ago
Roadmap Aims to Replace Animal Use in Toxicity Testingover 8 years ago
Acquity Arc Bio System Improves Bioseparation Analytical Methodsover 8 years ago
Corning Showcases 3D Cell Culture Technologies at SLAS 2018over 8 years ago
Novel Laboratory Automation Platform at SLAS 2018over 8 years ago
Comecar in $12-Million Deal to Equip German Cell Culture Labover 8 years ago
A Resurgence in Natural Product-Based Drug DiscoveryRelated to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.